[Treatment of epistaxis in Rendu-Osler disease by intramucosal injection of ethibloc].
The authors relate their one-year experience in percutaneous embolization of 12 patients presenting with severe epistaxis because of a Rendu Osler disease. Using Ethibloc a sclerosing substance derived from maize in direct intramucosal injection seems to be a promising technique. Ethibloc is still used successfully in percutaneous treatment of superficial venous angiomas.
Borsik
M
M
Service ORL, Hôpital Lariboisière, Paris.
Herbreteau
D
D
Deffrennes
D
D
Guichard
J P
JP
Aymard
A
A
Merland
J J
JJ
Tran Ba Huy
P
P
D000328:Adult; D000368:Aged; D003973:Diatrizoate; D004338:Drug Combinations; D004621:Embolization, Therapeutic / Q000379:methods*; D004844:Epistaxis / Q000209:etiology / Q000628:therapy*; D005227:Fatty Acids; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011409:Propylene Glycols; D011506:Proteins / Q000627:therapeutic use*; D012189:Retrospective Studies; D012597:Sclerosing Solutions; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications / Q000628:therapy*; D015028:Zein
D004338:Drug Combinations; D005227:Fatty Acids; D011409:Propylene Glycols; D011506:Proteins; D012597:Sclerosing Solutions; D003973:Diatrizoate; D015028:Zein; C020481:alcoholic prolamine solution
Le traitement des épistaxis de la maladie de Rendu-Osler par injection intramuqueuse d'éthibloc.